Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bicycle Therapeutics (BCYC – Research Report) and 60 Degrees Pharmaceuticals, Inc. (SXTP – Research Report).
Bicycle Therapeutics (BCYC)
TD Cowen analyst Tara Bancroft maintained a Buy rating on Bicycle Therapeutics today. The company’s shares closed last Tuesday at $22.87.
According to TipRanks.com, Bancroft is a 4-star analyst with an average return of
Bicycle Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $43.57.
See the top stocks recommended by analysts >>
60 Degrees Pharmaceuticals, Inc. (SXTP)
In a report released today, Edward White from H.C. Wainwright maintained a Hold rating on 60 Degrees Pharmaceuticals, Inc.. The company’s shares closed last Tuesday at $0.31, close to its 52-week low of $0.26.
According to TipRanks.com, White has 0 stars on 0-5 stars ranking scale with an average return of
60 Degrees Pharmaceuticals, Inc. has an analyst consensus of Hold.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BCYC:
